Impact of smoking on cardiovascular events in patients with stable coronary disease receiving contemporary medical therapy: a post hoc analysis of the Treating to New Targets trial

被引:0
|
作者
Frey, P. [1 ]
Waters, D. [1 ]
Pipe, A. [2 ]
Demicco, D. [3 ]
Breazna, A. [3 ]
Samuels, L. [3 ]
Benowitz, N. L. [4 ]
机构
[1] San Francisco Gen Hosp, San Francisco, CA 94110 USA
[2] Univ Ottawa, Inst Heart, Ottawa, ON, Canada
[3] Pfizer Inc, New York, NY USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:372 / 372
页数:1
相关论文
共 50 条
  • [1] Impact of Smoking on Cardiovascular Events in Patients With Established Coronary Disease Receiving Contemporary Medical Therapy: a Post Hoc Analysis of the Treating to New Targets (TNT) & the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Trials
    Frey, Paul F.
    Waters, David D.
    DeMicco, David A.
    Breazna, Andrei
    Samuels, Larry
    Pipe, Andrew L.
    Benowitz, Neal L.
    CIRCULATION, 2010, 122 (21)
  • [3] Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)
    Frey, Paul
    Waters, David D.
    DeMicco, David A.
    Breazna, Andrei
    Samuels, Larry
    Pipe, Andrew
    Wun, Chuan-Chuan
    Benowitz, Neal L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (02): : 145 - 150
  • [4] Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease
    Bouabdallaoui, Nadia
    Messas, Nathan
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tendera, Michal
    Naidoo, Datshana P.
    Hassager, Christian
    Steg, P. Gabriel
    Tardif, Jean-Claude
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (13) : 1460 - 1466
  • [5] Relationship of major cardiovascular events and 18 non-lipid biomarkers among patients with stable coronary disease and metabolic syndrome: a subanalysis of the treating to new targets trial
    Deedwania, P. C.
    Arsenault, B.
    Bao, W.
    Wenger, N. K.
    Barter, P.
    Grundy, S. M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 205 - 205
  • [6] Impact of Angina on Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease: A Post-Hoc Analysis From the COURAGE Trial
    Acharjee, Subroto
    Sidhu, Mandeep S.
    Hartigan, Pamela M.
    Teo, Koon K.
    Spertuss, John A.
    Maron, David
    Weintraub, William S.
    Boden, William E.
    CIRCULATION, 2013, 128 (22)
  • [7] PREDICTION OF CARDIOVASCULAR EVENTS IN STATIN-TREATED STABLE CORONARY PATIENTS WITH METABOLIC SYNDROME BY 18 NOVEL BIOMARKERS: THE TREATING TO NEW TARGETS (TNT) TRIAL
    Deedwania, Prakash C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] The Impact of Smoking on Cardiovascular Outcomes and Comorbidities in Statin-treated Patients with Coronary Artery Disease: A Post hoc Analysis of the GREACE Study
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Katsiki, Niki
    Gossios, Thomas D.
    Giouleme, Olga
    Anagnostis, Panagiotis
    Pagourelias, Efstathios D.
    Theocharidou, Eleni
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT VASCULAR PHARMACOLOGY, 2013, 11 (05) : 779 - 784
  • [9] The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease:: Prospective cohort study
    Twardella, D
    Rothenbacher, D
    Hahmann, H
    Wüsten, B
    Brenner, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 887 - 889
  • [10] Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers
    Arsenault, Benoit J.
    Barter, Philip
    DeMicco, David A.
    Bao, Weihang
    Preston, Gregory M.
    LaRosa, John C.
    Grundy, Scott M.
    Deedwania, Prakash
    Greten, Heiner
    Wenger, Nanette K.
    Shepherd, James
    Waters, David D.
    Kastelein, John J. P.
    PLOS ONE, 2014, 9 (12):